Overview

Effect of Alpha-Lipoic Acid Supplementation on the Incidence of Postoperative Atrial Fibrillation in Cardiac Surgery Patients

Status:
Recruiting

Trial end date:
2024-04-01

Target enrollment:

Participant gender:

Summary

ALA is administered orally since it is without difficulty absorbed in the stomach. ALA goes through the blood brain barrier and does not show toxic effects and actions at doses used for prophylactic and therapeutic purposes. This has encouraged us to use an efficient anti-oxidant and anti-inflammatory agent, alpha-lipoic acid (biochemical) as a relevant option to prevent POAF.

Phase:

Phase 4

Details

Lead Sponsor:

Ain Shams University

Treatments:

Thioctic Acid